

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:


(Alliance News) - Plus500 Ltd on Tuesday announced the launch of a US prediction markets platform with a regulated business-to-consumer offering.


(Alliance News) - JPMorgan Emerging Markets Dividend Income PLC joined the FTSE 250 index on Tuesday, replacing Dowlais Group PLC, whose acquisition b...


(Sharecast News) - Deutsche Bank cut its price target on JD Sports to 85p from 95p on Tuesday and kept its 'hold' rating as it said the retailer was "...


(Alliance News) - Stock prices in London opened higher, as the FTSE 100 hit a new intraday higher, amid a rebound in metal prices which buoyed miners.


KUWAIT, Feb 3 (Reuters) - The CEO of Kuwait Petroleum Corporation said on Tuesday that Kuwait Foreign Petroleum Exploration Company will sign...


Wizz Air Holdings PLC - Budapest-based budget airline - Carries 5.3 million passengers in January, up 8.5% from 4.9 million a year before. However, ca...


(Alliance News) - AstraZeneca PLC on Tuesday reported mixed news with progress for its cancer treatment Datroway, while US regulatory authorities requ...


Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use version of lupus ther...


(Alliance News) - UK grocery sales rose in January while inflation eased, according to new data from Wordpanel by Numerator on Tuesday, as own label s...


(Sharecast News) - Analysts at RBC Capital Markets updated its Centrica estimates ahead of the firm's 2025 year-end results, lowering its numbers but ...


(Alliance News) - AG Barr reports revenue growth and buys soft drink brands Fentimans and Frobishers, while Filtronic expects to meet market expectati...


* Bank of England watching food prices closely * Own label products account for 52.2% of January sales * Tesco and Sainsbury's win market share * A...


(Sharecast News) - Plus500 said on Tuesday that it has entered the US retail prediction markets through the launch of event-based contracts on its US ...


(Sharecast News) - The US health regulator has rejected an application by AstraZeneca to launch a self-injectable version of its lupus treatment Saphn...